icon
Treatmentsicon
Explore options
Our range of treatments are designed to help you lose weight
Discover icon
Mounjaro
21% weight loss treatment
Wegovy
17% weight loss treatment
Saxenda
10% weight loss treatment
Orlos
Weight loss capsules
Programmeicon
How it works
Treatments, coaching and habit change programme
Coaching
The support of a dedicated health coach
Voy app
Track your progress whilst creating healthy sustainable habits
Results
About
Experts
Resourcesicon
Guides & tips
Tools and tips for lasting weight loss
Research & science
Evidence-based insights and clinical research
icon
icon
menu-close
OVERVIEW
Treatment
icon
How it works
icon
Coaching
icon
Voy app
icon
EXPLORE
Results
icon
About
icon
Experts
icon
Resources
icon
ACCOUNT
Login
icon
GET IN TOUCH
020 3912 9885
Mon-Fri 9:00-17:30
icon
Explore options
icon
Mounjaro
icon
Wegovy
icon
Saxenda
icon
Orlos
icon
Guides & tips
icon
Research & science
icon
Home/Guides & Tips/Medications/

Mounjaro vs. Ozempic

Mounjaro vs Ozempic: Which is better for weight loss?

Mounjaro and Ozempic are different medications that can help with weight loss. Here’s how they stack up in terms of effectiveness, cost and side effects.

clinician image

Medically reviewed by

Dr Earim Chaudry (MBBS), Chief Medical Officer

iconPublished 1st May 2024
Research-Based Comparison
Table of contents
  • How does Mounjaro work?
  • How does Ozempic work?
  • Is Wegovy the same as Ozempic?...
  • Ozempic vs Mounjaro for weight...
  • What are the side effects of O...
  • Mounjaro vs Ozempic: Which one...
  • Your weight loss journey

Mounjaro and Ozempic are both weekly injections that can help with weight loss—and they’re each in pretty high demand.

But they differ in a lot of ways. For one, Ozempic is actually licensed as a treatment for type 2 diabetes, but is sometimes used off-label for weight. Mounjaro is approved for both diabetes and weight loss.

Plus, they’ve each been shown to drive different results, come with separate price tags, and use their own active ingredients. So, which one is best for you? To help you decide, here’s a head-to-head comparison of Mounjaro vs Ozempic for weight loss.

How does Mounjaro work?

Both Mounjaro and Ozempic work by making you feel full, so you eat less.

Mounjaro weight loss injections, which use the active ingredient tirzepatide, do that by acting like two of your body’s natural appetite-suppressing hormones: GLP-1 and GIP. Mimicking these hormones slows down your digestion and helps keep cravings at bay.

Discover Mounjaro
Learn more about Mounjaro as a weight loss treatment to make an informed decision.
icon
Science backed programme
icon
Personalised support
icon
Trusted by 65,000 customers across the UK

How does Ozempic work?

Ozempic slows digestion and suppresses your appetite, too. But it does that by acting like GLP-1 only. So, that makes it a GLP-1 receptor agonist.

Because Ozempic brings on the effects of one hormone, rather than two like Mounjaro, it’s considered the less potent medicine. It still works very well, though! Scroll down the page a bit to learn what sort of results it can drive.

FYI: Semaglutide is the active ingredient in Ozempic.

Is Wegovy the same as Ozempic?

Kind of. Ozempic and Wegovy are two different names for the same medicine. Both are brand names for semaglutide. That means they have the same effect on the body.

The difference is in how each medicine is used. Ozempic is licensed for type 2 diabetes while Wegovy is approved for weight loss. And they’re available in different doses. The highest strength of Ozempic is 2mg, while it’s 2.4mg for Wegovy.

So, if you’re interested in using Ozempic for weight loss, you’ll most likely be prescribed Wegovy instead.

Ozempic vs Mounjaro for weight loss: Which is more effective?

Now for the million-dollar question: Which medicine works better for weight loss? Let’s take a look at what the science says.

Heads up: In this bit we’ll be referring to Ozempic/Wegovy as semaglutide.

According to clinical research, Mounjaro comes out on top. In one trial, those taking Mounjaro lost an average of 25.3% of their starting weight after 88 weeks. That figure aligns with other studies, too. In a 72-week trial, the mean loss in people taking the highest strength of Mounjaro was 22.5%.

With semaglutide, the numbers are slightly lower (but still very impressive!). After 68 weeks of taking the medicine, one study showed that people lost 14.9% of their starting weight on average. An analysis of six clinical trials found that the average weight loss on semaglutide was 11.8% when taking it for up to 104 weeks.

But watch out. While scientific research can give you an idea of how well a medicine works, there’s no way to predict how it will affect you personally. These studies report average results from big groups of people, meaning that some lost more while others lost less.

If your numbers look different to the above—that’s totally fine. You’re on your own journey and you’ll reach your goals when you’re meant to.

What are the side effects of Ozempic vs Mounjaro?

Mounjaro and Ozempic/Wegovy have pretty similar side effects. Mostly, they’re related to the gut and tend to clear up on their own.

Here’s how common Mounjaro vs Ozempic side effects compare:

Very common side effects (affecting more than 1 in 10 people)

Both Ozempic/Wegovy and Mounjaro can cause a range of gastrointestinal symptoms. The most frequently reported side effects include:

  • Nausea
  • Vomiting
  • Constipation
  • Stomach pain
  • Diarrhoea

Additionally, Ozempic/Wegovy users may also experience:

  • Headache
  • Feeling weak or tired

Common side effects (affecting up to 1 in 10 people)

These side effects may still occur but are less common:

For both medications:

  • Dizziness
  • Upset stomach or indigestion
  • Burping
  • Gas
  • Bloating
  • Heartburn
  • Hair loss
  • Gallstones
  • Injection site reactions

Ozempic/Wegovy may also cause:

  • Gastritis
  • Change in how food tastes

Mounjaro may also cause:

  • Feeling tired
  • Low blood pressure

Side effects support at Voy

"If you're using Voy and you experience any side effects, rest assured that our expert clinicians are just a message or phone call away. They can adjust your dose, prescribe medication to ease your symptoms, or simply offer reassurance.

Everyone responds differently to weight loss treatment and we'll help you find what feels right for you."

Phoebe Fox - Weight Loss Specialist Clinician

What about ‘Ozempic face’?

To give you a quick refresher: this is a term for the gaunt, sunken look some people get in their face after they lose a lot of weight quickly. 

But despite its name, ‘Ozempic face’ doesn’t only happen to people taking Ozempic—or any weight loss injection, for that matter. It happens following a rapid drop in weight, however the method.

And actually, with weight loss medicines, the idea is that you lose weight gradually and sustainably over the long term—we’re talking a few percentage points of your body weight per month.

So, if you take your medication as advised and stick to your plan, you may be less likely to experience any gauntness or facial sagging. Though your face might look a bit more angular and slimmed down as you lose weight.

Mounjaro vs Ozempic: Which one is right for you?

This is a decision for you and your provider. They’ll consider your health and medical history, along with your treatment goals, when they make the call. 

For example, if you or anyone in your family has ever had a type of thyroid cancer called medullary thyroid carcinoma, it’s not recommended that you use Mounjaro.

And just to reiterate: because of how it’s licensed, your doctor would probably recommend Wegovy over Ozempic for weight loss.

Still undecided? Explore all Ozempic alternatives to find your best match.

Your weight loss journey

Whether you’re just starting out on your weight loss journey or have been at it for a while—we see you. We know how tough it can be to make changes and stick with them, especially when you aren’t seeing the results you hoped for.

If you can relate to that, weight loss medication might be a great option. When coupled with long-term lifestyle changes, they can help you lose up to 25% of your starting weight after at least a year.

Through our weight loss programme, you’ll work with our team of clinicians and coaches to build lifestyle habits that last—and receive monthly weight loss medication in the post. Our programme is backed by science and designed to drive sustainable, long-term results.

You can take your next step right now. Take our quiz to see if you’re eligible for the programme. Our clinicians will review your answers and come back to you right away.

Looking to start you weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
FAQ

Ozempic vs Mounjaro: FAQ

Dr Earim Chaudry, MBBS
DisclaimerAt Voy, we ensure that everything you read in our blog is medically reviewed and approved. However, the information provided is not meant to replace professional medical advice, diagnosis, or treatment. It should not be relied upon for specific medical advice.
References
icon¹

Aronne, Louis J, et al. “Continued Treatment with Tirzepatide for Maintenance of Weight Reduction in Adults with Obesity: the SURMOUNT-4 Randomised Clinical Trial.” JAMA,scribble-underline vol. 331, no. 1, 2024:38-48. https://jamanetwork.com/journals/jama/fullarticle/2812936.

icon²

Jastreboff, Ania M, et al. “Tirzepatide Once Weekly for the Treatment of Obesity.” The New England Journal of Medicinescribble-underline, vol. 387, no. 3, 2022:205-216 www.nejm.org/doi/full/10.1056/NEJMoa2206038.

icon³

“Mounjaro: Information for the Patient.” Electronic Medicines Compendium. scribble-underlinewww.medicines.org.uk/emc/files/pil.15481.pdf. Accessed 9 Apr. 2025.

icon⁴

“Mounjaro: Full Prescribing Information.” Food and Drug Administration.scribble-underline www.accessdata.fda.gov/drugsatfda_docs/label/2022/215866s000lbl.pdf. Accessed 9 Apr. 2025.

icon⁵

“Semaglutide for Managing Overweight and Obesity.” National Institute for Health and Care Excellence. scribble-underlinewww.nice.org.uk/guidance/ta875/chapter/2-Information-about-semaglutide Accessed 9 Apr 2025.

icon⁶

“Tirzepatide for Managing Overweight and Obesity.” National Institute for Health and Care Excellence. scribble-underlinewww.nice.org.uk/guidance/ta1026/chapter/2-Information-about-tirzepatide. Accessed 9 Apr 2025.

icon⁷

“Wegovy: Information for the Patient.” Electronic Medicines Compendium.scribble-underline www.medicines.org.uk/emc/files/pil.13800.pdf. Accessed 9 Apr. 2025.

icon⁸

Wilding, John P.H., et al. “Once-weekly Semaglutide in Adults with Overweight or Obesity.” The New England Journal of Medicinescribble-underline, vol. 384, no. 11, 2021:989-1002. www.nejm.org/doi/full/10.1056/NEJMoa2032183.

icon⁹

Willard, Francis S, et al. “Tirzepatide is an Imbalanced and Biased Dual GIP and GLP-1 receptor agonist.” JCI Insightscribble-underline, vol. 5, no, 17, 2020:e140532. https://pmc.ncbi.nlm.nih.gov/articles/PMC7526454/.

icon¹⁰

Qin, Wenhui, et al. “Efficacy and Safety of Semaglutide 2.4 mg for Weight Loss in Overweight or Obese Adults Without Diabetes: An Updated Systematic Review and Meta-analysis Including the 2-year STEP 5 Trial.” Obesity and Metabolismscribble-underline, vol. 26, issue 3, 2023:911-923 https://dom-pubs.pericles-prod.literatumonline.com/doi/10.1111/dom.15386.

card-image
Medication
Coming off Wegovy
Wondering what to expect when you stop taking Wegovy weight loss injections? Here’s the lowdown.
card-image
Medication
Mounjaro and HRT
Taking HRT but considering a weight loss injection like Mounjaro? Here are a few things to bear in mind.
card-image
Medication
Mounjaro benefits
Mounjaro doesn’t just help with weight loss. Here are some of the other health benefits users might expect.
card-image
Medication
Does Mounjaro affect birth control?
On the contraceptive pill and taking Mounjaro? Here are a few things to bear in mind.
Have a question?
Whatever it is, get in touch:
message
020 3912 9885Mon-Fri 9:00-17:00
message
help@joinvoy.comWe aim to reply in 24hrs
Mon-Fri 9:00-17:00
We aim to reply in 24hrs
Our services are not intended for use in a medical emergency. If you need urgent medical attention, please call 111 or 999

PROGRAMME

  • How it works
  • Treatments
  • Coaching
  • The Voy app

VOY

  • Results
  • About
  • Our medical experts

HELP

  • Help Centre (FAQ)
logo
Privacy PolicyTerms & Conditions
Terms of SaleComplaints
Pharmacies: Manual Pharmacy
Superintendent Pharmacist
Vinisha Kanda
GPhC Registration: 2203475
Copyright 2025 Voy™. All rights reserved.
cards
pharmacy-contact
Privacy Preference Center
We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below. The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. We also use third-party cookies that help us analyse how you use this website, store your preferences, and provide the content and advertisements that are relevant to you. These cookies will only be stored in your browser with your prior consent. You can choose to enable or disable some or all of these cookies but disabling some of them may affect your browsing experience.
Manage Consent Preferences
icon
Necessary Cookies
Always Active
Necessary cookies ensure the basic functionalities of the website, such as security, network management, and accessibility. These cookies cannot be disabled and do not store personal information.
icon
Preferences Cookies
Preferences cookies allow the website to remember information that changes the way the site behaves or looks, such as your preferred language or region.
icon
Statistics Cookies
Statistics cookies help us understand how visitors interact with the website by collecting and reporting information anonymously. These cookies provide insights into metrics such as page visits and traffic sources.
icon
Marketing Cookies
Marketing cookies are used to track visitors across websites. The intention is to display ads that are relevant and engaging for the individual user and more valuable to publishers and third-party advertisers.